What Remebot does

Remebot (柏惠维康) is a China-based surgical robotics company founded in 2010 that develops, manufactures, and sells minimally invasive surgical robot systems across three medical verticals: neurosurgery, orthopedics, and oral surgery. The company's core technology combines multi-modal image fusion (CT, MRI, PET, DTI), proprietary optical tracking and positioning (Reme-Intelligence™), and a six-axis robotic arm to deliver sub-millimeter precision (≤0.5mm for oral surgery, ≤1mm for neurosurgery) for complex procedures. Its flagship product is the Remebot (睿米) neurosurgical robot, which received China's first CFDA/NMPA Class III medical device registration for a neurosurgical robot in April 2018 and supports 12 categories of nearly 100 neurosurgical procedures including DBS, SEEG, biopsy, and hematoma aspiration. The company subsequently launched the Ruiyibo (瑞医博) oral surgery robot (China's first NMPA-approved oral surgical robot, April 2021), the orthopedic surgery robot with spine module, and the RM-50 brain hemorrhage robot variant, bringing its total to 8 NMPA product registrations.

Remebot generates revenue primarily through direct hardware sales of surgical robot systems to tertiary hospitals and dental clinics, supplemented by associated surgical planning software and modules. The company employs an enterprise field sales model targeting top-tier hospitals, with marketing supported by participation in major medical conferences (CNS, CAAE, China Med, CMEF, World Robot Conference), the Remebot Academy (睿米学院) surgeon training program, and PR through CCTV and other national media. By 2023 the company reported its products deployed across all 31 provinces of China, with expansion into Central Asian and Southeast Asian markets, and clinical collaborations with leading hospitals including Beijing Tiantan Hospital, Xuanwu Hospital, 301 Hospital, and nearly 30 top-tier hospitals, with over 20,000 clinical cases accumulated. Strategic partnerships include the National Neurosurgery Robot Application Demonstration Project with 9 leading hospitals and a distribution channel partnership with Shanghai Electric Medical Group. The company is headquartered in Chongqing (registered entity) with R&D operations in Beijing, holds 100+ IP rights including 70+ invention patents, and has raised approximately 560M RMB (~$85M) in cumulative disclosed funding including a 430M RMB Series D in December 2020 led by Zhongguancun Longmen Fund.

Name

Remebot

Legal name

柏惠维康（重庆）机器人股份有限公司

Website

https://remebot.com.cn

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Remebot (柏惠维康) is a China-based surgical robotics company founded in 2010 that develops and sells NMPA-approved neurosurgery, orthopedic, and oral surgery robot systems with sub-millimeter precision, serving tertiary hospitals and dental clinics across all 31 provinces of China.

Ownership category

akta.pro rank

Product category

Surgical Robotics

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Healthcare & Assistive Robotics (HDAAAIAC), Robot Hardware, Actuators & Components (sensors, grippers, motors) (HDAAAIAL)

Keywords

• Surgical robotics
• Neurosurgical navigation
• Dental implant robot
• Medical image fusion
• Robotic-assisted surgery

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Neurosurgical Surgical Robot Sales: Sale of Remebot neurosurgical surgical robot systems to hospitals, including hardware, software, and installation
2. Oral Surgery Robot Sales: Sale of Ruivbo (瑞医博) dental implant surgical robots to dental clinics and hospitals
3. Orthopedic Surgical Robot: Sale of orthopedic surgical robot products across three major medical fields: neurosurgery, orthopedics, and oral surgery

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

Remebot designs, manufactures, and sells surgical robot systems for neurosurgery, orthopedic, and oral/dental surgery. The flagship Remebot neurosurgery robot provides sub-millimeter positioning accuracy using multi-modal image fusion and optical tracking, supporting 12 categories of nearly 100 neurosurgical procedures. The Ruiyibo oral surgery robot handles dental implant procedures with ≤0.5mm distance deviation and ≤1° angle deviation. The orthopedic robot extends the platform to spine and bone procedures. Products are sold to hospitals and clinics with hardware, software, installation, and training bundled.

Product overview

Remebot (柏惠维康) is a surgical robotics company offering a portfolio of three core surgical robot brands spanning neurosurgery, orthopedics, and oral surgery. The flagship 睿米® neurosurgery robot received China's first CFDA Class III certification for neurosurgical robots in 2018, while 瑞医博® oral surgery robot became China's first domestically-developed oral surgery robot to receive NMPA approval in 2021. The company also offers 睿米® orthopedic robot. All three core brands share the company's proprietary Reme-Intelligence™ optical tracking system and surgical planning software platform. The neurosurgery system supports multiple add-on modules including endoscopy, navigation, and spine modules. The systems provide multi-modal image fusion (CT, MRI, PET, DTI), real-time optical tracking, and automated positioning for precise surgical navigation.

Differentiator

Problem solved

Functional benefit

Brands

• 睿米 (Remebot): Neurosurgical surgical robot brand. The flagship neurosurgical navigation and positioning system assists doctors in completing twelve categories of neurosurgical procedures with precision, minimal invasiveness, and high efficiency. Covers DBS, SEEG, aspiration/drainage, intracranial biopsy, percutaneous puncture, visual navigation, and endoscope navigation applications.
• 瑞医博 (Ruiyibo)
• 睿米 RM-50
• 睿见精彩 (Ruijian Jingcai)
• 睿米学院
• Reme-Intelligence
• 瑞医博 (Ruiyibo Dental Robot)

Products and services

• Remebot Neurosurgery Robot (睿米®神经外科手术机器人) Neurosurgery surgical navigation and positioning robot that assists doctors in performing minimally invasive, precise, and efficient neurosurgical procedures across 12 categories of nearly 100 types of surgeries including DBS (deep brain stimulation), SEEG (stereoelectroencephalography) electrode implantation, biopsy, hematoma aspiration, intracranial biopsy, percutaneous puncture, visual navigation, and endoscope navigation. Used by top-tier hospital neurosurgery departments.
• Ruiyibo Oral Surgery Robot (瑞医博®口腔手术机器人) Dental implant surgery robot that assists doctors in performing precise dental implant procedures with distance deviation ≤0.5mm and angle deviation ≤1°. Covers all tooth positions including immediate implantation in aesthetic zones, bone augmentation-assisted implantation, single jaw continuous multi-implant, full-arch edentulous implantation, zygomatic implantation, and embedded tooth window surgery. Used by hospital dental departments and dental implant clinics.
• Remebot Orthopedic Surgery Robot (睿米®骨科手术机器人) Orthopedic surgery robot for spinal and bone procedures. The spine module extends the neurosurgery robot's active safety technology to track six-dimensional spinal segment drift in real-time, guiding the robotic arm to actively correct positioning for precise spinal localization. Used by hospital orthopedic departments.
• Remebot RM-50 Brain Hemorrhage Surgical Robot (睿米®RM-50) Brain hemorrhage surgical robot variant, China's first NMPA-certified brain hemorrhage surgery robot product. Composed of independently-developed computer software (brain), optical tracking positioning system (eye), and domestic six-axis robotic arm (hand). Used for cerebral hemorrhage procedures.

Quantifiable outcome

• Positioning accuracy ≤0.5mm for oral surgery and ≤1mm for neurosurgery
• +4 more outcomes

Named customers9 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature6 records

Partnerships

Eight partnerships are on record, tiered flagship, major and minor.

• National Neurosurgery Robot Application Demonstration Project (国家神经外科手术机器人应用示范项目)flagshipStrategic or Co-development Partner · 1 September 2019Led by Ministry of Industry and Information Technology and National Health Commission; 9 leading hospitals as initiative members; completed over 1,000 robotic surgeries
• Beijing Tiantan Hospital (北京天坛医院)flagshipStrategic or Co-development Partner · 1 January 2019Lead hospital for clinical trials; pioneered first domestic robot-assisted DBS surgery; completed over 100 robotic surgeries
• Xuanwu Hospital (宣武医院)flagshipStrategic or Co-development PartnerClinical trial partner; collaborated on National Research Center for Medical Image Navigation Positioning Surgery Robot
• 301 Hospital (解放军总医院)flagshipStrategic or Co-development PartnerLed 5G remote surgery development; pioneer in remote robotic DBS procedures
• Shanghai Electric Medical Group (上海电气康达医疗)majorChannel Partner/ Reseller/ DistributorStrategic partnership for market expansion; exhibited at CMEF together; leverages Shanghai Electric's distribution network
• China Association for Medical Equipment (中国医学装备协会)minorOthersMember unit of China Association for Medical Equipment
• China Medical Equipment AI Alliance (中国医疗装备人工智能联盟)minorOthersCouncil member unit of China Medical Equipment AI Alliance
• Zhongguancun Frontier Technology and Industry Service Alliance (中关村前沿科技与产业服务联盟)minorOthersCouncil member unit

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Zimmer Biomet (Rosa): Operates the Rosa robotics platform for neurosurgery, spine, and knee. Comparable as a multi-indication incumbent whose neurosurgery and spine applications overlap with Remebot's Remebot neurosurgery robot and orthopedic spine module.
• Intuitive Surgical: Global leader in surgical robotics via the Da Vinci platform. While Remebot does not directly compete in laparoscopic soft-tissue robotics, Intuitive sets the benchmark for hospital capital sales, surgeon training, and recurring revenue economics that Remebot aspires to emulate.
• Medtronic (Mazor / StealthStation): Operates the Mazor robotic spine surgery platform and StealthStation surgical navigation — both direct competitors in the spinal and neurosurgical navigation indications where Remebot's spine module and Remebot neurosurgery robot compete.
• Stryker (Mako): Global orthopedic surgical robotics leader with the Mako platform. Comparable as a broad incumbent in orthopedic surgical robotics and a benchmark for hospital salesforce scale, clinical evidence generation, and capital equipment pricing strategy.

Direct peers

• TINAVI (天智航天智航): China's leading orthopedic/spine surgical robotics company and the first A-share listed domestic surgical robot maker. Directly comparable to Remebot's orthopedic franchise and competing in similar Chinese tertiary hospital channels.
• Shurui Robot (术锐机器人): Chinese single-port laparoscopic surgical robot developer competing for hospital capital budgets across multiple surgical specialties. Comparable as a domestic surgical robotics challenger targeting similar tier-1 Chinese hospital customers.
• Edge Medical (精锋医疗): China-based multi-port and single-port laparoscopic surgical robot company with NMPA approvals and growing hospital deployments. Comparable as a capital-rich Chinese surgical robotics peer competing for similar hospital procurement cycles.
• Neocis (Yomi): US-based dental implant surgical robot (Yomi), the first FDA-cleared dental implant robot. Direct comparable to Remebot's Ruiyibo oral surgery robot franchise in product category, regulatory pathway, and dental implant use case.
• Brainlab: Germany-based surgical navigation and robotics platform with significant neurosurgical and spine footprint. Closely comparable to Remebot's neurosurgical navigation and positioning technology in optical tracking, image fusion, and cranial/spinal use cases.
• Renishaw (Neuromate): UK-based manufacturer of the Neuromate stereotactic neurosurgical robot used for DBS, SEEG, and biopsy. Direct comparable in neurosurgical robotics technology and indications, though serving primarily European clinical sites.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds3 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Remebot